Vanda Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 6, 2026

Rhea-AI Summary

Vanda Pharmaceuticals (Nasdaq: VNDA) will release first quarter 2026 financial results on Wednesday, May 6, 2026 after market close. A conference call and simultaneous webcast will be held at 4:30 PM ET the same day to discuss the results and corporate activities.

Investors should register on Vanda's website at least 15 minutes early; a replay will be available from 8:30 PM ET on May 6, 2026 through 11:59 PM ET on May 13, 2026.

News Market Reaction – VNDA

+0.71%

+0.71% Session close to close

In the Apr 30 session, VNDA gained 0.71%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement sets the timing for Vanda’s first quarter 2026 earnings release and call on May 6,...

Analysis

This announcement sets the timing for Vanda’s first quarter 2026 earnings release and call on May 6, 2026 at 4:30 PM ET, without disclosing financial results yet. Shares traded at $7.05, above the $6.07 200-day MA, and the company recently reported $216.1 million in 2025 revenue with a net loss of $220.5 million. Investors may watch upcoming results, cash trends, and any use of the $200,000,000 shelf for further context.

Key Figures

Q1 2026 results date: May 6, 2026, 4:30 PM ET 2025 revenue: $216.1 million Year-end 2025 cash & securities: $263.8 million +5 more

8 metrics

Q1 2026 results date May 6, 2026, 4:30 PM ET Scheduled earnings release and conference call time

2025 revenue $216.1 million Total revenue in 2025 from Fanapt, HETLIOZ and PONVORY

Year-end 2025 cash & securities $263.8 million Cash and marketable securities at end of 2025

2025 net loss $220.5 million Full-year 2025 net loss after non-cash tax valuation allowance

Shelf registration size $200,000,000 Maximum aggregate offering under S-3 shelf filed Feb 12, 2026

BlackRock ownership 4.2% Schedule 13G/A reporting 2,508,488 shares with 2,206,827 sole voting power

Shares outstanding 60,135,062 Common shares outstanding as of April 17, 2026 record date

Short interest 10.18% Short interest as share of float, with 5.45 days to cover

Previous Earnings date Reports

1 past event · Latest: Feb 04 (Neutral)

Same Type Pattern 1 events

Date	Event	Sentiment	24h Move	Catalyst
Feb 04	Earnings date notice	Neutral	-4.9%	Set date and time for Q4 and full-year 2025 earnings release and call.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Tag-specific history is limited; the prior earnings-date notice saw a -4.87% move the next day.

Recent Company History

This announcement sets the date for Vanda’s first quarter 2026 results, continuing its pattern of pre-announcing earnings and hosting a 4:30 PM ET call and webcast. Earlier in 2026, Vanda highlighted board expansion, regulatory disputes with the FDA, and advancement of NEREUS™ into a Phase 2 trial with expected topline data by Q4 2026. A prior earnings-date notice on Feb 11, 2026 coincided with a -4.87% move, providing one reference point for how the market has reacted to similar scheduling news.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Conference Call and Webcast to Follow

WASHINGTON, April 29, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the first quarter 2026 on Wednesday, May 6, 2026, after the market closes.

Vanda will host a conference call at 4:30 PM ET on Wednesday, May 6, 2026, during which management will discuss the first quarter 2026 financial results and other corporate activities. To participate in the conference call, please dial 1-888-596-4144 (domestic) or 1-646-968-2525 (international) and use passcode 8051722.

The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.

A replay of the call will be available on Wednesday, May 6, 2026, beginning at 8:30 PM ET and will be accessible until Wednesday, May 13, 2026, at 11:59 PM ET. The replay call-in number is 1-800-770-2030 for domestic callers and 1-609-800-9909 for international callers. The passcode number is 8051722.

About Vanda Pharmaceuticals Inc.

Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.

Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com

Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-first-quarter-2026-financial-results-on-may-6-2026-302757650.html

SOURCE Vanda Pharmaceuticals Inc.

FAQ

When will Vanda Pharmaceuticals (VNDA) report first quarter 2026 results?

Vanda will report Q1 2026 results on Wednesday, May 6, 2026 after market close. According to the company, the release will be followed by a conference call and webcast at 4:30 PM ET the same day to discuss results and corporate activities.

How can investors join the Vanda (VNDA) May 6, 2026 conference call and webcast?

Investors can join by dialing 1-888-596-4144 (domestic) or 1-646-968-2525 (international) using passcode 8051722. According to the company, the call will also be broadcast and archived on Vanda's website and investors should register at least 15 minutes early.

Will Vanda (VNDA) provide a replay of the May 6, 2026 earnings call and for how long?

A replay will be available beginning 8:30 PM ET on May 6, 2026 and accessible through 11:59 PM ET on May 13, 2026. According to the company, domestic replay is 1-800-770-2030 and international replay is 1-609-800-9909 with passcode 8051722.

What will Vanda management discuss on the Q1 2026 conference call (VNDA)?

Management will discuss the first quarter 2026 financial results and other corporate activities. According to the company, the call is intended to cover results and additional corporate updates; no further content details were specified in the announcement.

Where can I find the Vanda (VNDA) webcast and registration for the May 6, 2026 call?

The webcast and registration are available on Vanda's investor website at www.vandapharma.com. According to the company, investors should visit the site at least 15 minutes before the call to register and install any required audio software.